Lukas D. Wartman

5.4k total citations
29 papers, 911 citations indexed

About

Lukas D. Wartman is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Lukas D. Wartman has authored 29 papers receiving a total of 911 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 17 papers in Hematology and 5 papers in Cancer Research. Recurrent topics in Lukas D. Wartman's work include Acute Myeloid Leukemia Research (16 papers), Retinoids in leukemia and cellular processes (8 papers) and Epigenetics and DNA Methylation (6 papers). Lukas D. Wartman is often cited by papers focused on Acute Myeloid Leukemia Research (16 papers), Retinoids in leukemia and cellular processes (8 papers) and Epigenetics and DNA Methylation (6 papers). Lukas D. Wartman collaborates with scholars based in United States, Japan and France. Lukas D. Wartman's co-authors include Yi-Zhong Gu, Timothy J. Ley, Tamara Lamprecht, John S. Welch, Peter Westervelt, John F. DiPersio, Michelle D. O’Laughlin, Nichole Helton, Shamika Ketkar and David A. Russler‐Germain and has published in prestigious journals such as Cell, Blood and PLoS ONE.

In The Last Decade

Lukas D. Wartman

27 papers receiving 895 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lukas D. Wartman United States 12 624 480 194 125 105 29 911
Matilda Rehn Sweden 12 382 0.6× 292 0.6× 285 1.5× 117 0.9× 61 0.6× 24 862
Jacky Chung United States 9 698 1.1× 360 0.8× 47 0.2× 117 0.9× 87 0.8× 15 932
Kimberly Lezon-Geyda United States 16 473 0.8× 200 0.4× 125 0.6× 135 1.1× 209 2.0× 34 860
Anh T. Nguyen United States 10 1.1k 1.8× 147 0.3× 174 0.9× 116 0.9× 49 0.5× 11 1.3k
Allison Mayle United States 10 788 1.3× 174 0.4× 462 2.4× 125 1.0× 50 0.5× 13 1.1k
Romulo Martin Brena United States 16 852 1.4× 232 0.5× 85 0.4× 132 1.1× 34 0.3× 19 1.1k
Michele M. Hickey United States 10 538 0.9× 612 1.3× 66 0.3× 146 1.2× 99 0.9× 11 1.1k
Hsiang‐Ying Lee Taiwan 18 728 1.2× 110 0.2× 210 1.1× 87 0.7× 129 1.2× 33 1.1k
Kerstin Enquist Sweden 15 476 0.8× 384 0.8× 44 0.2× 117 0.9× 73 0.7× 18 868
Tommaso Zanocco‐Marani Italy 18 543 0.9× 135 0.3× 84 0.4× 69 0.6× 72 0.7× 38 890

Countries citing papers authored by Lukas D. Wartman

Since Specialization
Citations

This map shows the geographic impact of Lukas D. Wartman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas D. Wartman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas D. Wartman more than expected).

Fields of papers citing papers by Lukas D. Wartman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukas D. Wartman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas D. Wartman. The network helps show where Lukas D. Wartman may publish in the future.

Co-authorship network of co-authors of Lukas D. Wartman

This figure shows the co-authorship network connecting the top 25 collaborators of Lukas D. Wartman. A scholar is included among the top collaborators of Lukas D. Wartman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukas D. Wartman. Lukas D. Wartman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shea, Lauren, Leigh A. Compton, Sai Mukund Ramakrishnan, et al.. (2022). Combined Kdm6a and Trp53 Deficiency Drives the Development of Squamous Cell Skin Cancer in Mice. Journal of Investigative Dermatology. 143(2). 232–241.e6. 6 indexed citations
2.
Ferraro, Francesca, Marianna B. Ruzinova, Christopher A. Miller, et al.. (2022). Decitabine salvage for <i>TP53</i>-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy. Haematologica. 107(7). 1709–1713. 7 indexed citations
3.
Christopher, Matthew, Margery Gang, Andrew J. Menssen, et al.. (2021). Tumor suppressor function of <I>WT1</I> in acute promyelocytic leukemia. Haematologica. 107(1). 342–346. 6 indexed citations
4.
Tian, Ling, et al.. (2021). Kdm6a deficiency restricted to mouse hematopoietic cells causes an age- and sex-dependent myelodysplastic syndrome-like phenotype. PLoS ONE. 16(11). e0255706–e0255706. 5 indexed citations
5.
Barnell, Erica K., Malachi Griffith, Zachary L. Skidmore, et al.. (2020). B-Cell Acute Lymphoblastic Leukemia Arising in Patients with a Preexisting Diagnosis of Multiple Myeloma Is a Novel Cancer with High Incidence of TP53 Mutations. Blood. 136(Supplement 1). 20–20. 3 indexed citations
7.
Fakhri, Bita, Amanda F. Cashen, Eric J. Duncavage, et al.. (2019). Fifty Shades of GATA2 Mutation: A Case of Plasmablastic Lymphoma, Nontuberculous Mycobacterial Infection, and Myelodysplastic Syndrome. Clinical Lymphoma Myeloma & Leukemia. 19(9). e532–e535. 2 indexed citations
8.
Campbell, Katie M., Tianxiang Lin, Paul Zolkind, et al.. (2018). Oral Cavity Squamous Cell Carcinoma Xenografts Retain Complex Genotypes and Intertumor Molecular Heterogeneity. Cell Reports. 24(8). 2167–2178. 23 indexed citations
9.
Wartman, Lukas D.. (2018). The future of cancer treatment using precision oncogenomics. Molecular Case Studies. 4(2). a002824–a002824. 4 indexed citations
10.
Jacoby, Meagan A., Eric J. Duncavage, Christopher A. Miller, et al.. (2018). Exome analysis of treatment‐related AML after APL suggests secondary evolution. British Journal of Haematology. 185(5). 984–987. 1 indexed citations
11.
Ali, Alaa M., Feng Gao, Geoffrey L. Uy, et al.. (2017). Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10‐day decitabine regimen. Cancer Medicine. 6(12). 2814–2821. 21 indexed citations
12.
Menssen, Andrew J., et al.. (2017). Expression of the Tumor Suppressor WT1 Is Induced By PML-Rara in Acute Promyelocytic Leukemia. Â. Blood. 130. 2508–2508. 3 indexed citations
13.
Tian, Ling & Lukas D. Wartman. (2017). The Role of Kdm6a in Malignant Hematopoiesis. Blood. 130. 1227.
14.
Spencer, David H., David A. Russler‐Germain, Shamika Ketkar, et al.. (2017). CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression. Cell. 168(5). 801–816.e13. 149 indexed citations
15.
Lu, Charles, Peter A. Riedell, Christopher A. Miller, et al.. (2016). A common founding clone with TP53 and PTEN mutations gives rise to a concurrent germ cell tumor and acute megakaryoblastic leukemia. Molecular Case Studies. 2(1). a000687–a000687. 15 indexed citations
16.
Wartman, Lukas D.. (2015). A case of me: clinical cancer sequencing and the future of precision medicine. Molecular Case Studies. 1(1). a000349–a000349. 8 indexed citations
17.
Grieselhuber, Nicole R., Jeffery M. Klco, Tamara Lamprecht, et al.. (2013). Notch signaling in acute promyelocytic leukemia. Leukemia. 27(7). 1548–1557. 25 indexed citations
18.
Wartman, Lukas D., John S. Welch, Geoffrey L. Uy, et al.. (2012). Expression and Function of PML-RARA in the Hematopoietic Progenitor Cells of Ctsg-PML-RARA Mice. PLoS ONE. 7(10). e46529–e46529. 12 indexed citations
19.
Doray, Balraj, Jane M. Knisely, Lukas D. Wartman, Guojun Bu, & Stuart Kornfeld. (2008). Identification of Acidic Dileucine Signals in LRP9 that Interact with Both GGAs and AP‐1/AP‐2. Traffic. 9(9). 1551–1562. 29 indexed citations
20.
Gu, Yi-Zhong, et al.. (1998). Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha.. PubMed. 7(3). 205–13. 468 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026